<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Beta-catenin, a protein that functions in both cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and Wnt signaling, plays vital roles in mammalian neural development </plain></SENT>
<SENT sid="1" pm="."><plain>To investigate the roles of beta-catenin in <z:hpo ids='HP_0001297'>stroke</z:hpo>-induced neurogenesis, we injected beta-catenin siRNA into ipsilateral ischemic lateral ventricle </plain></SENT>
<SENT sid="2" pm="."><plain>We found that inactivation of beta-catenin by siRNA caused the decline of beta-catenin in the ischemic striatum, enlarged <z:hpo ids='HP_0001297'>stroke</z:hpo>-induced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, reduced SVZ expansion, and inhibited striatal neurogenesis in adult rat brain following a transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (tMCAO) </plain></SENT>
<SENT sid="3" pm="."><plain>These results show that beta-catenin-mediated transcriptional activation functions in the decision of subventricular zone precursors to proliferate or differentiate during <z:hpo ids='HP_0001297'>stroke</z:hpo>-induced striatal neurogenesis, and suggest that the signaling activity of beta-catenin may control the production of newborn neurons and thus regulate the autonomous repair in the striatum after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>